Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence.
Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence.
复制标题
DOI：
10.1097/inf.0000000000003685
复制
发表时间：
2022-12-01
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
美国指南推荐使用干扰素γ释放试验（IGRAs）诊断儿童结核感染。在这项回顾性队列研究中，IGRA在2-17岁儿童中的使用在2015-2021年间大幅增加。在住院/亚专科环境（与初级保健），公共（与私人）保险，较低的年龄和非英语首选语言的测试与接受IGRA的几率增加。
US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2–17 years of age increased substantially between 2015–2021. Testing in inpatient/subspecialty settings (vs primary care), public (vs private) insurance, lower age, and non-English preferred language were associated with increased odds of receiving an IGRA.